Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_3
1
33%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown267%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_2

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

NCT06541574
unknownnot_applicable

Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis

NCT06150794
unknownphase_3

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

NCT05751512

Clinical Trials (3)

Showing 3 of 3 trials
NCT06541574Phase 2

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

Recruiting
NCT06150794Not Applicable

Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis

Unknown
NCT05751512Phase 3

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3